Baxter International (BAX) Receives a Sell from Morgan Stanley
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Wood covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Baxter International, and Cooper Co. According to TipRanks, Wood has an average return of -1.0% and a 50.00% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Baxter International with a $37.27 average price target.
BAX market cap is currently $15.75B and has a P/E ratio of -27.94.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Globe Life price target raised to $171 from $166 at Morgan Stanley
Morgan Stanley raised the firm's price target on Globe Life (GL) to $171 from $166 and keeps an Overweight rating on the shares. Following Q2 results, the firm is updating its price targets for stocks in the Life Insurance segment under its coverage, the analyst tells investors. Nearly half of the life insurers under its coverage beat expectations on a reported basis and most exceeded expectations on a core basis, the firm adds. Morgan Stanley notes the earnings beats were largely driven by selective favorable underwriting, better than expected performance of macro-sensitive segments, or both. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on GL: Disclaimer & DisclosureReport an Issue Globe Life announces dual listing on NYSE Texas Morgan Stanley Says a New Bull Market Is Underway — Here Are 2 Stocks to Bet on It Globe Life upgraded to Overweight from Equal Weight at Morgan Stanley Globe Life price target raised to $149 from $114 at BMO Capital Positive Regulatory Outcomes Reinforce Buy Rating for Globe Life Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Voya Financial price target raised to $90 from $89 at Morgan Stanley
Morgan Stanley raised the firm's price target on Voya Financial (VOYA) to $90 from $89 and keeps an Overweight rating on the shares. Following Q2 results, the firm is updating its price targets for stocks in the Life Insurance segment under its coverage, the analyst tells investors. Nearly half of the life insurers under its coverage beat expectations on a reported basis and most exceeded expectations on a core basis, the firm adds. Morgan Stanley notes the earnings beats were largely driven by selective favorable underwriting, better than expected performance of macro-sensitive segments, or both. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on VOYA: Disclaimer & DisclosureReport an Issue Voya Financial Reports Strong Q2 2025 Performance Voya Financial's Earnings Call Highlights Growth and Strategy Voya Financial price target raised to $90 from $87 at UBS Voya Financial Reports Q2 2025 Financial Results Voya Financial reports Q2 adjusted EPS $2.46, consensus $2.06 Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
Aflac price target raised to $113 from $108 at Morgan Stanley
Morgan Stanley analyst Bob Huang raised the firm's price target on Aflac (AFL) to $113 from $108 and keeps an Equal Weight rating on the shares. Following Q2 results, the firm is updating its price targets for stocks in the Life Insurance segment under its coverage, the analyst tells investors. Nearly half of the life insurers under its coverage beat expectations on a reported basis and most exceeded expectations on a core basis, the firm adds. Morgan Stanley notes the earnings beats were largely driven by selective favorable underwriting, better than expected performance of macro-sensitive segments, or both. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on AFL: Disclaimer & DisclosureReport an Issue Cautious Outlook on AFLAC: Sell Rating Due to Future Challenges Despite Current Performance Aflac price target raised to $106 from $105 at Evercore ISI Aflac approves increase in share repurchase program Aflac price target raised to $107 from $105 at Wells Fargo Aflac price target raised to $108 from $106 at Keefe Bruyette Sign in to access your portfolio
